High Vista Strategies LLC Pliant Therapeutics, Inc. Call Options Transaction History
High Vista Strategies LLC
- $230 Million
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PLRX
# of Institutions
149Shares Held
62.6MCall Options Held
279KPut Options Held
7.1K-
Tang Capital Management LLC San Diego, CA6MShares$9.96 Million0.53% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.4MShares$8.96 Million0.25% of portfolio
-
Black Rock Inc. New York, NY4.97MShares$8.25 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.33MShares$5.54 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.05MShares$5.07 Million0.0% of portfolio
About PLIANT THERAPEUTICS, INC.
- Ticker PLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,682,000
- Market Cap $80.8M
- Description
- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...